Overexpression of the human epidermal growth factor receptor-2 (Her-2) gene, a breast cancer marker, is associated with rapid tumour growth, increased risk of recurrence after surgery, poor response to conventional chemotherapy and shortened survival3. The gene discussed is ERBB2; the disease is neoplasm.